量子血疗对机体免疫功能影响的临床观察

该光量子血疗的患者,其治疗前后抽甸检测免疫功能指标发现,紫外线照射自血回输地确有提高高机体细胞免疫功能作用。治疗后淋巴细胞转化率,淋巴细胞亚群及中性粒细胞吞噬功能测定都有不同程度提高（Ｐ〈０．０１）。     

自血光量子疗法对放射治疗鼠肿瘤增敏作用的研究

本文应用多功能图像分析仪,检测了鼠Ｗ２５６移植性肿瘤细胞ＤＮＡ含量,探讨自血池子量子疗法（ＵＢＩ）对放射治疗的增敏作用,结果表明,经ＵＢＩ后放疗与单纯放疗的肿瘤相比,肿瘤细胞ＤＮＡ含量显著降低,而且肿瘤体积减小,细胞变性坏死显著,间质淋巴细胞数量明显增多,表明ＵＢＩ对肿瘤放射治疗有明显的增敏作用。     

复方蛾公口服液对小鼠免疫功能的影响

本文论述了复方蛾公口服液对小鼠溶血空斑、腹腔巨噬细胞吞噬功能及Ｔ淋巴细胞转化率的影响．充分证明了复方蛾公口服液对小鼠免疫功能有明显增强作用。     

珍奥酵母核酸对环磷酰胺致小鼠免疫功能低下的影响

目的 通过环磷酰胺致小鼠免疫功能低下,建立BALB/C小鼠免疫功能低下模型,评价珍奥酵母核酸对小鼠免疫功能低下的作用.方法 选用BALB/C小鼠,随机分组,分别给予相应的处理,选择T淋巴细胞亚群CD69+/CD3+比值、NK细胞亚群CD69+/NKG2D+比值、淋巴细胞转化率及血清IL-2含量作为细胞免疫的指标.结果 核酸各剂量组和添加剂组均可使免疫低下小鼠外周血和脾的T淋巴细胞亚群CD69+/CD3+比值、NK细胞亚群CD69+/NKG2D+比值提高,同时可提高免疫低下小鼠淋巴细胞转化率及IL-2水平,尤以高、中剂量核酸组和添加剂组明显(P＜0.05).结论 珍奥酵母核酸可以提高免疫低下小鼠的免疫功能,以其为珍奥酵母核酸的临床应用及提高机体免疫力提供了实验依据.     

升血汤促进辐射损伤小鼠造血与免疫功能恢复的实验研究

本文研究了中药升血汤对辐射损伤小鼠造血与免疫功能恢复的促进作用,结果证明,升血汤能显著地增加辐射损伤小鼠外周血中各类血细胞数以及骨髓及脾脏中的有核细胞数,明显促进小鼠巨噬细胞,Ｔ及Ｂ淋巴细胞功能的恢复,表明升血汤可以明显促进辐射损伤小鼠造血与免疫功能的恢复。     

酵母SH2产胞外糖蛋白对小鼠免疫功能的影响

酵母菌ＳＨ２产细胞外糖蛋白在体外实验中能明显提高正常小鼠ＮＫ活性淋巴细胞转化率以及白细胞数;对环磷酰胺所致的免疫受抑小鼠的免疫功能也有恢复作用,显示出酵母菌ＳＨ２产胞外糖蛋白具有免疫调节功能。     

香菇菌发酵液的免疫调节作用

本文报道了香菇菌发酵液对原发性肝癌患者及不同免疫功能状态下的小鼠的免疫调节作用。结果表明,香菇菌发酵液可增加由环磷酰胺（ＣＰ）诱导的免疫功能低下的治疗组小鼠的脾细胞数,增强小鼠抗体形成细胞的功能,增加溶血素抗体产生,但其作用对预防组小鼠不明显。香菇菌发酵液能促进ＣｏｎＡ诱导的脾淋巴细胞转化（ＬＴ）,增加免疫玫瑰花环形成细胞（ＩＲＦＣ）率,提高红细胞Ｃ_３ｂ受体花环（ＲＢＣ－Ｃ_３ｂＲＲ）结合率。１８例原发性肝癌患者的体外ＬＴ及ＲＢＣ－Ｃ_３ｂＲＲ     

两种芽生病毒免疫治疗小鼠H_（22）腹水瘤的实验研究

本文采用ＮＤＶ（新城鸡瘟病毒）和副流感病毒腹腔注射治疗６１５纯系Ｈ２２腹水瘤,取得良好的疗效。ＮＤＶ治疗组存活率为４０％;副流感病毒治疗组存活率为４５％;ＮＤＶ和副流感病毒交叉免疫治疗Ｈ２２腹水瘤小鼠存活率为４３．７％,并对治疗Ｈ２２腹水瘤进行免疫功能的检测。观察了ＮＤＶ和副流感病毒治疗组与对照组的免疫指标的变化。其淋巴细胞转化率、ＮＫ细胞活性、抗体生成细胞以及Ｅａ花环形成率均比对照组明显提高。同时进行病毒在体内感染肿瘤细胞增强其抗原性的观察。本文并进行病毒治疗肿瘤的机理的探讨。     

大脑前额叶皮层与免疫机能的关系Ⅰ.损毁前额叶皮层对猕猴淋巴细胞免疫机能的影响

用临床细胞免疫学检测方法,对损毁大脑前额叶背外侧部皮层手术前、手术后７天和手术后３０天的猕猴外周血液淋巴细胞的４种免疫花环（Ｅｔ、Ｅａ、ＺＹＣ和ＭＥ花环）进行了跟踪监测,并与假手术组进行对照。结果表明：损毁大脑前额叶皮层后,其外周血活化Ｔ淋巴细胞花环率（Ｅａ）和Ｂ淋巴细胞的小鼠红细胞花环率（ＭＥ）均在手术后７天显著下降;直到手术后３０天仍显著低于手术前。而总Ｔ淋巴细胞花环率（Ｅｔ）和酵母多糖补体复合物花环率（ＺＹＣ）则在手术后７天显著下降,在手术后３０天又回复。这些结果提示：大脑前额叶皮层对机体免疫机能具有一定的调节联系作用,损毁大脑前额叶皮层后,可引起机体淋巴细胞免疫功能下降,其作用机理尚待进一步研究     

酵母SH2产胞外糖蛋白对小鼠免疫功能的影响

酵母菌SH2产细胞外糖蛋白在体内与体外实验中能明显提高正常小鼠NK活性和淋巴细胞转化率以及白细胞数;对环磷酰胺所致的免疫受抑小鼠的免疫功能也有恢复作用.显示出酵母菌SH2产胞外糖蛋白具有免疫调节功能.     

光量子加血卟啉疗法对大鼠肿瘤放射增敏作用的对比研究

本文应用透射电子显微镜技术观察了应用血卟啉加光量子疗法后,再施以放射治疗,大鼠皮下移植性肿瘤Ｗ２５６细胞超微结构的变化,结果表明,与单纯充氧放疗组的肿瘤细胞相比,经过血卟啉,光量子疗法及同时应用血卟啉和光量子疗法后再施放疗组大鼠组织周围有明显增多的炎性细胞浸润及淋巴细胞浸润;肿瘤细胞可见有不同程度的核改变及粗面内质脱颗闰,扩张：线粒体肿胀,嵴及膜的断裂,基质丢失,应用血卟啉及血卟啉加光量子同时应用     

光量子和血卟啉的放疗增敏作用与表皮生长因子关系的研究

本文采用放射免疫技术检测了充氧及充氧并用光量子或血卟啉和光量子与血卟啉联合治疗后进行局部放射治疗皮下Ｗ２５６移植瘤大鼠的血浆、瘤组织和颌下腺组织内表皮生长因子（ＥＧＦ）的含量。结果表明,与单纯充氧后放射治疗组大鼠比较：（１）光量子治疗组、血卟啉治疗组和光量子与血啉卟联合治疗组大鼠血浆ＥＧＦ含量显著升高（Ｐ〈０．０５）;（２）光量子治疗组、血卟啉治疗组和光量子与血卟啉联合治疗组大鼠组织与颌下腺中ＥＧ     

Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy

The rationale for using transfer factor (TF) in lung cancer patients is that the possibility of improving their cell-mediated immunity to tumour associated antigens (TAA) may improve their survival. From Jan 1984 to Jan 1995, 99 non-small cell lung cancer (NSCLC) resected patients were monthly treated with TF, extracted from the lymphocytes of blood bank donors. In the same period, 257 NSCLC resected patients were considered as non-treated controls. The survival rates of the TF treated group appear significantly improved both for patients in stages 3a and 3b, and patients with histological subtype “large cell carcinoma” (P<0.02). Survival of TF treated patients is also significantly higher (P<0.02) for patients with lymphnode involvement (N2 disease). The results of this study suggest that the administration of TF to NSCLC resected patients may improve survival.     

Transfer factor induced delayed hypersensitivity in X-linked combined immunodeficiency

A 5-month-old male with an X-linked combined immunodeficiency was treated with transfer factor. Consequently, lymphocyte stimulation to phytohemagglutinin and Candida as well as delayed hypersensitivity to candida and 2,4-dinitrochlorobenzene developed and persisted for 4 weeks. When cellular immunity diminished, the patient succumbed to Pneumocystis carinii and cytomegalovirus infections. Because of the transfer of cellular immunity in this case, further trials of transfer factor are indicated when histocompatible bone marrow is not available for patients with combined immunodeficiency.     

小细胞肺癌患者外周血淋巴细胞亚群分析

目的 探究化疗对小细胞肺癌(small cell lung cancer,SCLC)患者免疫功能的影响。 方法 选择2013年1月到2018年12月我院收治的95例小细胞肺癌患者为研究对象。患者第一周期、第二周期化疗前采用流式细胞术检测患者外周血淋巴细胞亚群水平,分别按照不同疗效及不同化疗方案对患者外周血淋巴细胞亚群进行比较。 结果 (1)化疗后,95例患者CD3+、CD4+、CD8+细胞平均值增加,CD19+、γδT细胞平均值减少,差异均有统计学意义(均P+、CD8+细胞平均值增加,CD19+细胞减少,差异有统计学意义(均P0.05)。(3)依托泊苷联合顺铂(EP)方案组化疗后患者CD3+、CD8+细胞平均值增多,CD19+细胞减少,差异均有统计学意义(均P0.05)。 结论 化疗可以调节小细胞肺癌患者的免疫功能,增强细胞免疫,降低体液免疫,其中EC方案对患者细胞免疫的增强作用较为显著。     

Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?

The predominant mode of radiation-induced cell death for solid tumours is mitotic catastrophe, which is in part dependent on sublethal damage repair being complete at around 6 h. Circadian variation appears to play a role in normal cellular division, and this could influence tumour response of radiation treatment depending on the time of treatment delivery. We tested the hypothesis that radiation treatment later in the day may improve tumour response and nodal downstaging in rectal cancer patients treated neoadjuvantly with radiation therapy. Recruitment was by retrospective review of 267 rectal cancer patients treated neoadjuvantly in the Department of Radiation Oncology at the Canberra Hospital between January 2010 and November 2015. One hundred and fifty-five patients met the inclusion criteria for which demographic, pathological and imaging data were collected, as well as the time of day patients received treatment with each fraction of radiotherapy. Data analysis was performed using the Statistical Package R with nonparametric methods of significance for all tests set at p < 0.05. Of the 45 female and 110 male patients, the median age was 64. Seventy-three percent had cT3 disease and there was a mean tumour distance from the anal verge of 7 cm. Time to surgical resection following radiotherapy ranged from 4 to 162 days with a median of 50 days, with a complete pathological response seen in 21% of patients. Patients exhibiting a favourable pathological response had smaller median pre- and postradiotherapy tumour size and had a greater change in tumour size following treatment (p < 0.01). Patients who received the majority of their radiotherapy fractions after 12:00 pm were more likely to show a complete or moderate pathological response (p = 0.035) and improved nodal downstaging. There were also more favourable responses amongst patients with longer time to surgical resection postradiotherapy (p < 0.004), although no relationship was seen between response and tumour distance from the anal verge. Females were less likely to exhibit several of the above responses. Neoadjuvant radiotherapy for locally advanced rectal cancer performed later in the day coupled with a longer time period to surgical resection may improve pathological tumour response rates and nodal downstaging. A prospective study in chronomodulated radiotherapy in this disease is warranted.     

Experimental Salmonellosis XI. Induction of Cellular Immunity and Formation of Antibody by Transfer Agent of Mouse Mononuclear Phagocytes

When mice were injected intraperitoneally with a ribonucleic acid (RNA) preparation extracted from the peritoneal mononuclear phagocytes (termed monocytes) of immunized mice, these macrophages developed cellular immunity and cellular antibodies. The peritoneal monocytes were obtained from normal mice and maintained in tissue culture bottles in a homogeneous cell population. When they were treated in vitro with an immune RNA preparation, they acquired cellular immunity, and cellular antibodies were detectable in such monocytes. These results suggest that the mononuclear phagocytic cell line constitutes a cell line responsible for antibody formation.     

放疗联合食管支架对晚期食道癌患者预后影响的COX分析

目的:分析放疗联合食管支架对晚期食道癌患者预后影响。方法:选取我院收治晚期食道癌患者90例,经西医诊断标准经病理学及CT检查确诊为晚期食道癌,根据治疗方法不同分为实验组(放疗联合食管支架术)与对照组(食管支架术)。比较患者肝、肾功能,及生存率。采用Cox分析法对患者预后与放疗的相关性分析。结果:两组患者半年、1年、3年、5年生存率相比较,实验组与对照组相比较,生存率升高,差异具有统计学意义(P0.05);经COX分析,食管癌患者的生存率与患者的淋巴结转移书、TNM分期以及是否放疗有关(P0.05);经COX分析后可见,是否有食管瘘、是否根治术、病理分型、TNM分期、是否放疗为影响食管癌患者生存的独立影响因素(P0.05)。结论:是否有食管瘘、是否根治术、病理分型、TNM分期、是否放疗是食管癌患者生存的独立影响因素。术后的放疗治疗对患者的生存有积极意义。     

Behaviour of lymphocytes from cancer patients and normal individuals cultured with phytohaemagglutinin.

Blood lymphocytes from cancer patients with solid tumours without any previous immunosuppressive treatment and from normal individuals, were cultured in vitro with a wide range of phytohaemagglutinin (PHA). Sixty two per cent of all the cancer patients studied show a minimal of no response to PHA in comparison with the normal population. The rest (38%), show a quantitative identical response than normals. However, the maximal response in these patients occur in the high PHA doses, while the normal individuals show their maximal activity with low PHA doses. The low or no PHA response showed by the 62% of patients, may indicate they have impaired cellular immunity. The high response showed by the other 38%, may indicate that the patients of this group have high cellular immunity capacity. This immunity, however, higher PHA doses are required to reach the maximal response compared with the seems to be different from that of normal individuals, since higher PHA doses are required in cancer patients to reach maximal response. These results also suggest that a large range of PHA doses may be important to detect the degree of cellular immunity in cancer patients compared with the normal population. One or two random PHA doses, may not show a distinction.